The case for genomic patenting
- PMID: 8524376
- DOI: 10.1038/378534a0
The case for genomic patenting
Abstract
Opposition to the patenting of genomic inventions threatens to erode the foundation of intellectual property rights needed to convert innovative research into new drugs, vaccines and diagnostic tests.
Comment in
-
Gene patenting.Nature. 1996 Jan 11;379(6561):111. doi: 10.1038/379111b0. Nature. 1996. PMID: 8538757 No abstract available.
-
Ethics of genomic patenting.Nature. 1996 Jan 25;379(6563):294. doi: 10.1038/379294a0. Nature. 1996. PMID: 8552178 No abstract available.
-
Why genes can be patented.Nature. 1996 Feb 8;379(6565):484. doi: 10.1038/379484a0. Nature. 1996. PMID: 8596622 No abstract available.
-
Genes, patents and insurance.Nature. 1996 Feb 22;379(6567):672. doi: 10.1038/379672a0. Nature. 1996. PMID: 8602206 No abstract available.
-
Merck, SmithKline and patents.Nature. 1996 May 30;381(6581):360. doi: 10.1038/381360a0. Nature. 1996. PMID: 8632785 No abstract available.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
